Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH announcement about terminology changes during a federal transition is no longer displayed above the page.SummaryDifference1%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces an NIH terminology transition, stating that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check25 days agoChange DetectedThe revision label in the footer changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with a basic error screen. This blocks access to the full study record and navigation.SummaryDifference18%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.